Company: SHPH
Filing Date: 2025-09-18
Form Type: 8-K
Source: 0001493152-25-014097
Chunk: 0

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-09-18
Form: 8-K
Item: Item 5.02
Chunk 0
---
Item
5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.

On
September 12, 2025, Sachin Pathigoda and Angel Liriano were appointed as directors of Shuttle Pharmaceuticals Holdings, Inc. (the “ Company”).
On September 15, 2025, Mr. Pathigoda was also appointed as the Chairman of the Nominating and Corporate Governance Committee and Mr.
Liriano was appointed as the Chairman of the Compensation Committee. In addition, Mr. Pathigoda was appointed as a member of the Audit
Committee and Mr. Liriano was appointed as a member of the Nominating and Corporate Governance Committee.

In addition, George Scorsis, a director
of the Company, was appointed as Chairman of the Audit Committee.

There
are no family relationships between Mr. Pathigoda or Mr. Liriano and any of the Company’s directors or executive officers. Neither
Mr. Pathigoda nor Mr. Liriano have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item
404(a) of Regulation S-K. There were no arrangements or understandings by which Mr. Pathigoda and Mr. Liriano were appointed as directors
of the Company..

   2  

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

  SHUTTLE                                                      
  Dated:                                                       
  By:                                 /s/                      
  Name:                               Christopher              
  Title:                              Interim                  

   3